Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.79p
   
  • Change Today:
      0.050p
  • 52 Week High: 9.80p
  • 52 Week Low: 4.88p
  • Currency: UK Pounds
  • Shares Issued: 201.37m
  • Volume: 477,661
  • Market Cap: £13.67m
  • RiskGrade: 510

Latest Deals

No deals were found in the last 365 days.

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Synairgen Market Data

Currency UK Pounds
Share Price 6.79p
Change Today 0.050p
% Change 0.74 %
52 Week High 9.80p
52 Week Low 4.88p
Volume 477,661
Shares Issued 201.37m
Market Cap £13.67m
RiskGrade 510

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
59.03% above the market average59.03% above the market average59.03% above the market average59.03% above the market average59.03% above the market average
68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average
Price Trend
68.66% below the market average68.66% below the market average68.66% below the market average68.66% below the market average68.66% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Synairgen Dividends

No dividends found

Trades for 05-Jun-2024

Time Volume / Share Price
16:25 118,086 @ 6.90p
16:21 29,535 @ 6.50p
16:21 20,000 @ 6.54p
16:16 465 @ 6.50p
16:16 2,185 @ 6.52p

Synairgen Key Personnel

CEO Richard J Marsden

Top of Page